UPCOB LC (DRUG)

UPCOB LC is a premium neuroprotective and metabolic combination targeting diabetic and nutritional neuropathy through multiple complementary mechanisms.

L-Carnitine L-Tartrate 500mg: L-Carnitine is the obligatory transporter for long-chain fatty acids across the inner mitochondrial membrane — it forms acylcarnitine esters with activated fatty acids (acyl-CoA) and ferries them into the mitochondrial matrix for beta-oxidation. Without adequate carnitine, mitochondrial fatty acid oxidation is impaired, reducing ATP production in tissues with high energy demands (cardiac muscle, skeletal muscle, peripheral nerve axons). In the neuropathic context, carnitine supplementation restores endoneurial energy metabolism in peripheral nerve fibres, supports myelin synthesis (myelin is lipid-rich, dependent on fatty acid oxidation for formation and maintenance), and has been shown in clinical trials to improve nerve conduction velocity and reduce neuropathic pain scores — particularly in diabetic peripheral neuropathy.

Methylcobalamin 1500mcg: The active neurological form of vitamin B12, distinct from cyanocobalamin in that it is directly usable as a methyl donor without conversion steps. Methylcobalamin is incorporated directly into myelin sheaths as a cofactor for methionine synthase — enabling the remethylation of homocysteine to methionine and the synthesis of S-adenosylmethionine (SAM), the universal methyl donor for myelin basic protein methylation and DNA methylation. At 1500mcg, this provides therapeutic doses specifically validated for peripheral neuropathy — above the standard supplement dose and in the range used in clinical neuropathy trials.

Alpha Lipoic Acid (ALA): A powerful endogenous antioxidant that regenerates other antioxidants (vitamins C, E, glutathione) and directly quenches reactive oxygen species in both aqueous and lipid environments. ALA's unique amphipathic antioxidant activity makes it particularly effective for protecting nerve tissue — which is highly susceptible to oxidative damage from the hyperglycaemia-driven superoxide production in diabetic neuropathy. ALA supplementation has Level I evidence for improving neuropathic symptoms in diabetic peripheral neuropathy in multiple European clinical trials.

Folic Acid + Chromium: Folic acid reduces homocysteine (neurotoxic at elevated levels, a risk factor for neuropathy progression); chromium enhances insulin receptor sensitivity, reducing the hyperglycaemia that drives oxidative nerve damage.

UPCOB LC is indicated for peripheral neuropathy and neuropathic conditions where metabolic, nutritional, and antioxidant support are required alongside disease-specific management.

Diabetic Peripheral Neuropathy (Primary): The most prevalent indication — affecting approximately 50% of diabetic patients over a lifetime. L-carnitine + methylcobalamin + ALA addresses the energy deficit, myelin demyelination, and oxidative stress that together produce the characteristic burning pain, paraesthesia, and nerve conduction slowing of diabetic neuropathy.

B12-Deficiency Neuropathy: Methylcobalamin 1500mcg as a therapeutic dose for B12 neuropathy — affecting vegetarians, elderly, and metformin users (metformin reduces intestinal B12 absorption).

Post-COVID Neuropathy: Peripheral nerve involvement in post-COVID syndrome — ALA's antioxidant and carnitine's mitochondrial support are emerging as relevant in post-viral neuropathic conditions.

Chemotherapy-Induced Peripheral Neuropathy: L-carnitine and ALA have evidence for reducing chemotherapy-induced neuropathy from taxanes and platinum compounds.

Alcoholic Neuropathy: Carnitine deficiency and B12 deficiency are both prevalent in chronic alcohol use — UPCOB LC addresses both simultaneously.

Carpal Tunnel Syndrome and Other Compressive Neuropathies: Methylcobalamin's axonal regeneration support and ALA's anti-inflammatory properties are used adjunctively in compressive neuropathies.

Dosage and administration should be as prescribed by a qualified doctor or medical professional. Do not self-medicate. Always follow your physician's instructions regarding dose, frequency and duration of treatment.